MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2026 International Congress

    Adult-Onset Stereotypies and Cortical Myoclonus: An Unusual Presentation of Cerebral Amyloid Angiopathy

    N. Doan, T. Tran (Ho Chi Minh City, Viet Nam)

    Objective: To report a case of secondary adult-onset stereotypies with cortical myoclonus associated with an underlying neurological disorder. Background: Stereotypies are repetitive, patterned, rhythmic, non–goal-directed…
  • 2026 International Congress

    Preservation of Cognition Following Intravenous Mesenchymal Stem Cell Therapy in Parkinson’s Disease: Secondary Analysis of a Randomized Trial

    J. Martinez-Lemus, T. Thomas, C. Green, T. Ellmore, F. Triolo, S. Olson, J. Suescun, E. Tharp, C. Onuigbo, R. Ritter Iii, M. Schiess (Houston, USA)

    Objective: To evaluate longitudinal changes in global cognition following intravenous allogeneic bone marrow–derived mesenchymal stem cell (allo-hBM-MSC) therapy in Parkinson’s disease (PD). Background: Cognitive impairment…
  • 2026 International Congress

    Correlation between handwriting and cognitive function in patients with Parkinson’s disease

    S. Obika, O. Montero, J. Ortega, M. Escribano, A. Ruiz-Yanzi, C. Del Toro, E. Natera-Villalba, C. Gasca-Salas, M. Matarazzo, R. Martínez-Fernández, F. Alonso-Frech (Madrid, Spain)

    Objective: To investigate whether handwriting performance in Parkinson’s disease (PD) patients is associated with neuropsychological function. Background: PD patients typically present impaired handwriting with slower…
  • 2026 International Congress

    Changes in ADL-Related Factors According to Disease Stage in Patients with Parkinson’s Disease: Multiple Regression Analysis

    K. Watanabe, T. Nakamura, G. Horiguchi, H. Miyamoto, Y. Yamazaki, Y. Kameyama, E. Kitahara, K. Haruyama, N. Nishikawa, T. Hatano, N. Hattori, T. Fujiwara (Bunkyo-ku, Japan)

    Objective: To identify factors associated with activities of daily living (ADL) according to disease stage in patients with Parkinson’s disease (PD). Background: PD is a…
  • 2026 International Congress

    Personality Dynamics and Cognitive Impairment and Related Neuropsychiatric Symptoms in Patience with Different Movement Disorders

    M. Kulsum, M. Naaz, A. Das, A. Das, T. Dolai, S. Majumdar (Kolkata, India)

    Objective: To find out the prevalence of Eysenck’s Personality type among the patients with different movement disorders.To find out the relationship between cognitive impairments and…
  • 2026 International Congress

    Real-World Clinical Experience With Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion In Advanced Parkinson’s Disease Patients With Mild Cognitive Impairment And History Of Psychosis

    MN. Afkir Ortega, E. Navarro Mocholi, I. Sastre Bataller, M. Campins Romeu, C. Morata Martínez, R. Baviera Muñoz, J. Perez Garcia, I. Martinez Torres (Valencia, Spain)

    Objective: To describe the efficacy and safety of continuous subcutaneous infusion of foslevodopa/foscarbidopa (LDp/CDp) in advanced Parkinson’s disease (aPD) in routine clinical practice, focusing on…
  • 2026 International Congress

    Latent Classes of Cognitive Decline in Parkinson’s Disease: Neuroimaging and Neurodegenerative Blood Biomarker Correlates

    MC. Mckenna, M. Pasternak, R. Alesker, S. Mirza, S. Black, C. Marras, M. Binns, D. Breen, K. Fishman, D. Grimes, B. Levine, P. Mclaughlin, A. Troyer, R. Bartha, H. Zetterberg, A. Lang, M. Masellis (Toronto, Canada)

    Objective: To identify longitudinal trajectories of cognitive decline in Parkinson’s disease (PD) and to characterize neuroimaging and neurodegenerative blood biomarker correlates. Background: Cognitive impairment affects…
  • 2026 International Congress

    Temporal Ordering of Biomarker Abnormality Events Leading to Cognitive Impairment in Parkinson’s Disease: A Disease Event-Based Model Analysis of the PPMI Cohort

    A. Negida (Richmond, USA)

    Objective: To estimate the temporal ordering of multimodal biomarker abnormality events leading to cognitive impairment in PD using a Disease Event-Based Model (DEBM), incorporating clinical,…
  • 2026 International Congress

    Cognitive Profile In Indian Patients with Spinocerebellar Ataxia (SCA) – Prospective Cross-sectional Study

    A. Patel, M. Bhatt, A. Aggarwal (Mumbai, India)

    Objective: To evaluate the prevalence, spectrum, and severity of cognitive impairment in Indian patients with genetically confirmed SCA and corelate with motor severity. Background: Beyond…
  • 2026 International Congress

    High-Frequency rTMS for Cognitive Impairment in Parkinson’s Disease: A Randomized Sham-Controlled Trial in Veterans

    Y. Kim, S. Walker, K. Colletta, A. Umbarger, S. Kletzel (Maywood, USA)

    Objective: To evaluate the safety, feasibility, and potential cognitive effects of high-frequency rTMS targeting the left DLPFC in Veterans with PD-MCI. Background: Cognitive impairment is…
  • 1
  • 2
  • 3
  • …
  • 141
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley